You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
[the_ad_placement id="main-ldb-public"]
[the_ad_placement id="main-ldb-mobile-public"]

You are reading 1 of 2 free-access articles allowed for 30 days

HSE launches review as OST patients rise by over 6%

By Dermot - 17th Aug 2020 | 6 views

Dr Bobby Smyth

The HSE is reviewing the response of addiction services during the acute phase of the pandemic, this newspaper has learned. The number of patients attending for methadone treatment and in receipt of buprenorphine/naloxone (Suboxone) increased during the height of the Covid-19 crisis by over 6 per cent.

“As we emerge from the acute phase of the Covid-19 crisis, the [HSE’s] national social inclusion office is carrying out a review of the response of the addiction service during the crisis including the rapid induction process,” a HSE spokesperson told the Medical Independent (MI) last month.
“The review will inform service developments in the context of a situation where a significant number of individuals with complex needs were provided with opioid substitution treatment (OST), creating resource and capacity issues that also need review.”

At the end of May, 10,805 patients were receiving methadone, while in January that figure was 10,233. There was also a steady increase in the number of patients in receipt of Suboxone during the acute phase of the Covid-19 crisis. At the end of May, that figure was 340 compared to 262 in February.

In total there were 11,145 OST patients at the end of May compared to 10,495 before the Covid-19 crisis began at the end of January. This represented a 6.2 per cent increase during the pandemic, according to the HSE. Speaking to MI last month, Consultant Child and Adolescent Psychiatrist Dr Bobby Smyth praised the performance of the addiction services during the pandemic. “What was terribly impressive is that there has been absolute continuity in that treatment from the very start. The provision of methadone, the substitution aspect of treatment, has been enhanced as opposed to reduced,” he outlined.

“Where patients were identified as having a need to cocoon because they were at risk of infection themselves, mechanisms were developed so that their medications were brought to them or collected by someone else to be brought to them.”

Leave a Reply

[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]
Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

[the_ad_placement id="main-mpu-public"]
Most Read
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]